Compare · Fat-loss peptide
Adipotide vs AOD-9604
Both are fat-loss peptide compounds. Here's how they line up on the evidence — graded the same way.
| Adipotide | AOD-9604 | |
|---|---|---|
| Evidence | Animal only | Preliminary human |
| Class | Fat-loss peptide | Fat-loss peptide |
| Summary | A pro-apoptotic peptidomimetic that kills the blood vessels feeding white fat. It produced striking fat loss in obese mice and monkeys, but never cleared safety into meaningful human testing — the lone human trial enrolled four patients and reported no results. | A growth-hormone fragment marketed for fat loss. The human trials were small and short, the pivotal obesity study failed, and development was abandoned. Unapproved as a drug everywhere. |
| Full profile → | Full profile → |
Adipotide
Adipotide (FTPP) is one of the more mechanistically dramatic experimental obesity compounds: instead of curbing appetite, it is designed to kill the blood supply feeding white fat. The animal data — in mice and in monkeys — are genuinely striking. But the human story is almost nonexistent: a single…
AOD-9604
AOD-9604 is a synthetic peptide once developed as an anti-obesity drug. It is now sold widely as a "fat-loss peptide," but the human trials behind it are small, short, and ultimately disappointing.